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Abstract
Background:  Formal checks of participant understanding are now widely recommended to
improve informed consent processes. However, the views of the participants these assessments
are designed to protect are rarely considered. In this paper the findings of a qualitative study aimed
at documenting community reactions to a semi-structured questionnaire ('quiz') are reported. The
quiz was administered to 189 mothers after consenting for their children to participate in a malaria
vaccine trial on the Kenyan Coast.
Methods: Once the malaria vaccine trial was underway, focus group discussions were held with
some of these mothers (nine groups; 103 mothers), and with community-based field staff attached
to the malaria vaccine trial (two groups of five workers). Individual interviews with other trial staff
were also held.
Results: The quiz prompted community members to voice concerns about blood sampling and
vaccine side-effects, thereby encouraging additional discussions and interactions between the
research team and potential study participants. However, it also caused significant upset and
concern. Some of the quiz questions, or the way in which they were asked, appeared to fuel
misconceptions and fears, with potentially negative consequences for both the study and
community members.
Conclusion:  Formal approaches to checking study understanding should be employed with
sensitivity and caution. They are influenced by and impact upon complex social relationships
between and among researchers and community members. Adequate consideration of these
contexts in assessments of understanding, and in responding to the issues raised, requires strong
social science capacity.
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Background
Individual informed consent is a key ethical obligation for
clinical studies. However, empirical studies show that the
key requirements are often not met [1-5]. Suggestions for
improving informed consent abound [2-12], but few have
been evaluated in the field.
There is some evidence that a formal assessment, admin-
istered during the informed consent process, improves
understanding[4]. Checks of study comprehension, often
in the form of a simple quiz with a check-list of facts, are,
therefore, increasingly recommended for clinical stud-
ies[10,13,14]. In a recently published Nuffield discussion
document, the monitoring of participants' understanding
by a separate team was described as a 'valuable addition to
many trials conducted in developed countries, where partici-
pants may have an incomplete understanding of the implica-
tions of their participation' [14]. The need to assess
participants' general understanding of the implications of
the trial, rather than to simply test their retention of infor-
mation with a check-list, was emphasized.
In this paper, community reactions to a semi-structured
questionnaire aimed at exploring participant perceptions
and understanding of a malaria vaccine trial are described.
The trial was conducted at the KEMRI-Wellcome Trust
Collaborative Research Programme on the Kenyan Coast.
The trial, information giving processes, and community
perceptions and understanding of the trial itself are
described in detail elsewhere[15,16]. Briefly, information-
giving included: creating awareness of the study among
community representatives and the general community at
public meetings, and then with parents in their own
homes; holding detailed group and individual discus-
sions with parents who volunteered to attend the local
dispensary to enrol their children in the trial; and a further
explanation of the study at least a week after signing con-
sent, just prior to administration of the vaccine (Figure 1).
The findings of the questionnaire (or quiz) are briefly
reported here. The unexpected reactions to the quiz are
then described in more detail, in order to inform appro-
priate consenting processes in similar communities. This
research was part of a protocol reviewed and approved by
the Kenyan National Ethical Review Committee (No.
925).
Methods
The Social and Behavioural Research (SBR) group coordi-
nate community liaison activities at the KEMRI-Wellcome
Trust Research Programme. SBR members (SM, CG and
VM) adapted a quiz passed by the local and national eth-
ics review committees into a semi-structured question-
naire (hereafter 'quiz') administered to 189 caretakers,
primarily mothers (see Additional file 1). The quiz was
administered by four experienced SBR fieldworkers, all of
whom were from the same locality as the participants and
had been carefully trained in communication skills. To
avoid disrupting consenting and clinical screening proc-
esses, caretakers were interviewed just prior to their depar-
ture from the dispensary on the screening day (Step 3;
Figure 1). Community reactions to the quiz itself were ini-
tially raised by the community to the trial field staff and
PI (PB) and were then explored by CG through focus
group discussions with community members (n = 9) and
fieldworkers (n = 2) once the trial was underway. Com-
munity members were mothers of children in the trial,
selected on the basis of village of residence. Focus Group
Discussions (FGDs) continued to be held until a point of
redundancy was reached (no new information being pre-
sented in the groups).
Results and Discussion
The proportion of correct responses regarding different
key study details ranged from 29% to 85% (Table 1), and
the proportion responding 'don't know' from 14% to
45%. 35% of participants responded to the question 'what
is this work for' with a correct response. Most participants
providing an 'incorrect' response described vaccine or
malaria prevention work in general terms, without speci-
fying testing for safety or potential efficacy of a malaria
vaccine. In subsequent FGDs, and in responses to other
Table 1: Correct and don't know answers on key vaccine trial 
study information
Question Correct 
response %
Stating 
DK %
What is this research for? 35 26
Why vaccine can't be given to all Kenyan 
children at the moment?
48 45
If you're child is healthy, and take part, how 
many injections will they receive?
49 31
Will all children be given a malaria vaccine? 85 16
Why will you have to stay at the clinic for 
one hour after the injection
80 14
Will children who have received a vaccine 
be able to get malaria?
29 44
Formal information giving processes organised by vaccine  trial team Figure 1
Formal information giving processes organised by vaccine 
trial team.
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questions, it appeared that many more parents did in fact
understand that the study was a trial, and that the prob-
lem was primarily with the question and it's administra-
tion rather than with participant knowledge. For the
remaining questions, 'incorrect' responses included 6% (n
= 11) reporting that all children would be given a malaria
vaccine, 18% (n = 35) that their child would receive one
or two rather than three injections, and 20% (n = 39) that
children with the vaccine would have assured protection
against malaria infection.
No concerns were openly vocalized about the quiz itself
while it was being administered. However, over the course
of quiz one mother became increasingly agitated and
finally withdrew from the study, demanding that her
child's blood sample be returned and destroyed to prevent
'devil-worshipping'. Many other potential participants
observed this dramatic and public event. Discussions
around it revealed that rumours were widespread in the
community: rumours that the information given by the
research team is a lie; that unnecessarily large samples of
blood are taken to be sold or given to devils (often associ-
ated with 'wazungus', or foreigners); that children will fit
and die immediately after the vaccine is administered;
that children will slowly die off after the end of the vaccine
trial; and that biscuits and juice are given to children to
increase their blood for further blood taking for devils.
Recognition of the huge sensitivity around blood sam-
pling led to public meetings at which the PI showed and
answered questions about how blood is processed and
used in the laboratory; including demonstrations of
microscope slides and assay wells. These meetings were an
opportunity to focus on an area that had not been covered
in depth in previous information giving sessions. More
importantly, they were an additional opportunity for
community members to test the research teams' openness
and consistency in messages. These are behaviours sup-
portive of trust-building, and appeared essential to the
successful conduct of the trial (see also Gikonyo et al
[16]).
Over the course of public meetings and in other informal
interactions, concerns about the quiz itself began to
emerge. Questions about the quiz were, therefore,
included in FGDs with fieldworkers and community
members. In almost all FGDs, participants mentioned at
least one disadvantage of the quiz. An important view
expressed in community groups was that the questions
asked, and the way they were asked, heightened concerns
about rumours circulating in the community; and that
raising concerns in this way was unnecessary (see above
event, and Quotes 1–3; Figure 2). Further concerns
included: people were not given a specific explanation of
the quiz in previous information giving steps and so were
not prepared for it; a person was being taken 'very far and
interviewed alone'; and possible poor verbal and non-ver-
bal communication by interviewers (Figure 2, quote 4).
Reports of questions asked suggest that either the ques-
tions were being confused with a larger census that is on-
going in the area, or that some of the interviewers embel-
lished the questions and contributed to the concerns
raised (Figure 2; quote 5). Participants' concerns about the
questions may have led to a relatively high level of 'don't
know' responses to the quiz, either in protest at the ques-
tions, or in an attempt to gather additional information
from SBR fieldworkers to cross-check vaccine trial team
information.
In six FGDs participants mentioned at least one positive
aspect of the quiz, including that it helped people under-
stand, gave them a chance to seek clarification on specific
issues (from the study team or friends and relatives), and
assisted in decision-making about study participation
(Figure 3; Quotes 1 and 2). Those who reacted badly were
Examples of the participants' positive comments about the  quiz Figure 3
Examples of the participants' positive comments about the 
quiz.
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sometimes reported not to have understood, and any con-
cerns raised were reportedly resolved once the trial began. 
Nevertheless, the quiz was clearly an unnerving experi-
ence for some participants (Figure 2; Quote 6), particu-
larly given the relatively low education level of many
mothers compared with the field assistants interviewing
them. One person wondered what good the quiz did for
those who decided not to join, because many of the
rumours circulating in the community were proven
untrue (for example children did not die immediately
after receiving the first vaccine), and because those not in
the trial did not benefit from careful monitoring and free
treatment: P: (Interrupted a discussion on the positive
aspects of the quiz)... it helped some; those who decided to
continue coming. But then those that misunderstood, it didn't
help them because they ran away! So, did they finish the jour-
ney?
Conclusion
Formal approaches to checking study understanding are
increasingly popular for clinical research. The findings
presented in this paper suggest that any such checks
should be employed with sensitivity and caution. In the
absence of other studies that have formally explored this
issue, the experiences in Kenya suggest the following key
issues influencing community reactions and the validity
of the quiz itself:
The interviewer. The value of quizzes is dependent on the
interpersonal skills of the people administering it, and
their ability to ask questions in an open and non-threat-
ening way. Difficulties were faced in Kenya even with
fieldworkers fluent in the local language who were care-
fully trained in qualitative methodologies and in commu-
nication skills. Interviewers from within the team may
have been more appropriate in this case.
Qualitative versus quantitative data. The findings of quan-
titative data acquired can be misleading without comple-
mentary qualitative data. Using quiz data alone to make
definitive comments on individual levels of understand-
ing or eligibility to access a trial is not therefore recom-
mended. Imbalances in resources and research knowledge
between researchers and community members can also
make individual interviews intimidating for participants.
In Kenya, a qualitative, group based, or less formal quiz
may well have achieved the same positive impacts for all
with fewer concerns raised for community members.
The follow up provided after a quiz. A formal check of
understanding can lead to difficulties for individuals, for
the community and for researchers in the short term. Nev-
ertheless, this is an opportunity for the issues raised to be
dealt with, leading to better understanding on both sides,
and a stronger relationship between participants and
researchers. This is particularly the case if the assessment
is incorporated into and informs a broader strategy for
involving communities in aspects of the research.
Expertise is required. Developing, administering and
responding to assessments of understanding for clinical
trials requires significant social science capacity. Strength-
ening the role of good quality social science in clinical tri-
als is an important strategy for improving ethical practice.
The findings may be specific to the study population and
to the socio-cultural and institutional context of the study.
Use of a similar quiz in phase 1 trials, on a much smaller
sample size of well-educated parents, provoked less con-
troversy. However this was not formally explored. Further
studies on quizzes would indicate the generalizability of
the findings and identify important contextual influences.
A greater understanding of community perspectives on
quizzes, and of other ethical requirements, will help give
research participants and communities a voice in national
and international debates on how to strengthen ethical
practice.
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